Business Description
DNA X Inc
NAICS : 541519
SIC : 5045
ISIN : US83548F3091
Total Employee Number:
4Description
DNA X Inc is engaged in providing crypto trading services through its online platform, enabling users to buy, sell, and exchange cryptocurrencies, as well as execute automated trading strategies between currency pairs. The company generates revenue from commissions and fees on trading activity.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 1.12 | |||||
Equity-to-Asset | -0.02 | |||||
Debt-to-Equity | -12.92 | |||||
Debt-to-EBITDA | -0.14 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -96.76 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 65.2 | |||||
3-Year EPS without NRI Growth Rate | 50.4 | |||||
3-Year FCF Growth Rate | 25.1 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 34.21 | |||||
9-Day RSI | 34.89 | |||||
14-Day RSI | 37.68 | |||||
3-1 Month Momentum % | 27.13 | |||||
6-1 Month Momentum % | -5.02 | |||||
12-1 Month Momentum % | -60.95 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.76 | |||||
Quick Ratio | 0.76 | |||||
Cash Ratio | 0.28 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -87.2 | |||||
Shareholder Yield % | -185.06 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 49.97 | |||||
Operating Margin % | 57.83 | |||||
Net Margin % | 88.36 | |||||
EBITDA Margin % | 46.06 | |||||
FCF Margin % | 103.98 | |||||
OCF Margin % | 103.98 | |||||
ROA % | -45.89 | |||||
ROIC % | -39 | |||||
3-Year ROIIC % | 20.91 | |||||
ROC (Joel Greenblatt) % | -6715.95 | |||||
Years of Profitability over Past 10-Year | 1 | |||||
Moat Score | 4 | |||||
Tariff Resilience Score | 3 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 2.89 | |||||
EV-to-EBIT | -0.43 | |||||
EV-to-EBITDA | -0.6 | |||||
EV-to-Forward-EBITDA | 0.51 | |||||
EV-to-Revenue | -0.28 | |||||
EV-to-Forward-Revenue | 0.03 | |||||
EV-to-FCF | -0.27 | |||||
Price-to-GF-Value | 0.11 | |||||
Earnings Yield (Greenblatt) % | -232.56 | |||||
FCF Yield % | -363.88 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:SONM
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
DNA X Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | -16.721 | ||
| EPS (TTM) ($) | -23.48 | ||
| Beta | 1.2482 | ||
| 3-Year Sharpe Ratio | -0.68 | ||
| 3-Year Sortino Ratio | -0.89 | ||
| Volatility % | 126.77 | ||
| 14-Day RSI | 37.68 | ||
| 14-Day ATR ($) | 0.602214 | ||
| 20-Day SMA ($) | 4.272245 | ||
| 12-1 Month Momentum % | -60.95 | ||
| 52-Week Range ($) | 2.5211 - 16.973999 | ||
| Shares Outstanding (Mil) | 1.49 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
DNA X Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
DNA X Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-10-30 | In 100 days | ||
| Second quarter earnings results for 2026 | 2026-08-07 17:07 | In 17 days | ||
| General meeting for 2026 | 2026-07-24 09:00 | In 3 days | ||
| First quarter earnings results for 2026 | 2026-05-20 | 4.30 (-8.68%) | ||
| Annual report for 2025 | 2026-04-15 | 3.35 (+6.69%) | ||
| Third quarter earnings results for 2025 | 2025-10-31 | 11.12 (+4.12%) | ||
| 0.0555556:1 Stock Split | 2025-10-27 | 12.68 (+4.56%) | ||
| Second quarter earnings results for 2025 | 2025-08-08 17:07 | 10.98 (-3.17%) | ||
| General meeting for 2025 | 2025-07-18 09:00 | 14.11 (+4.55%) | ||
| First quarter earnings results for 2025 | 2025-05-12 | 24.96 (+1.20%) |
Show
Entries
DNA X Inc Frequently Asked Questions
What is DNA X Inc(SONM)'s stock price today?
The current price of SONM is $3.25. The 52 week high of SONM is $16.97 and 52 week low is $2.52.
When is next earnings date of DNA X Inc(SONM)?
The next earnings date of DNA X Inc(SONM) is 2026-08-07 Est..
Does DNA X Inc(SONM) pay dividends? If so, how much?
DNA X Inc(SONM) does not pay dividend.
Guru Commentaries on NAS:SONM
No articles.
Press Release
Articles on DNA X Inc
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers